Skip to main content
. Author manuscript; available in PMC: 2017 Apr 18.
Published in final edited form as: Clin Gastroenterol Hepatol. 2015 Sep 25;14(5):753–759. doi: 10.1016/j.cgh.2015.08.041

Table 1.

Admission Characteristics by Intervention Phase

Intervention Phase
Control (n=626) Checklist (n=470) Electronic (n=624) p-value
Age - Mean (SD) 55.8 (11.2) 56.1 (11.3) 58.3 (11.3) 0.009
Female Sex - % 36.3% 42.8% 36.9% 0.61
Non-White Ethnicity - % 20.1% 31.9% 29.7% 0.029
Charlson Comorbidity Index - Mean (SD) 4.23 (2.63) 4.0 (2.6) 4.4 (2.7) 0.093
Model for End-Stage Liver Disease Score - Mean (SD) 17.7 (7.08) 17.7 (7.1) 17.4 (7.5) 0.46
Admission Sodium Level (meq/L)- Mean (SD) 134.4 (5.65) 134.5 (5.8) 134.3 (5.9) 0.89
Admission in Past 30 days - % 22.7% 22.1% 16.7% 0.041
Payor= Medicare or Private Insurance - % 70.6% 73.0% 72.9% 0.82
Primary Etiology of Liver Disease (%) (%, does not sum to 100)
Alcoholic Liver Disease 34.0% 30.0% 29.3% 0.39
Hepatitis C 44.9% 40.4% 40.2% 0.50
Hepatitis B 5.4% 4.47 4.3% 0.64
Biliary Cirrhosis 1.8% 4.5% 2.4% 0.63
Active Problems during hospitalization (%, does not sum to 100)
Gastrointestinal Bleeding 28.3% 29.8% 31.9% 0.59
Ascites 43.6% 43.8% 43.6% 1.0
Hepatic Encephalopathy 47.8% 43.8% 47.4% 0.72
Spontaneous Bacterial Peritonitis 6.9% 6.6% 9.1% 0.25
Alcoholic Hepatitis 7.8% 9.2% 5.6% 0.11
Hepatocellular Carcinoma 3.4% 2.5% 5.3% 0.32
Previous Transplant 19.3% 22.8% 21.3% 0.63

SD = standard deviation